GNTX · Gentex Corp
The AI's read
That gives investors a less favorable outside view of Gentex shares. The story reports no new sales or profit figures, so it does not show that Gentex's business itself has changed.
Goldman Sachs moved Gentex from Neutral to Sell and cut its target from $23 to $20 per share. The lower target sits below Monday's $21.91 closing price, pointing to a weaker view of its shares.
That gives investors a less favorable outside view of Gentex shares. The story reports no new sales or profit figures, so it does not show that Gentex's business itself has changed.
BTIG moved Personalis from Buy to Neutral, showing a less favorable view of its shares. The report gives no new company results to suggest a change in its business.
Piper Sandler cut Goosehead's rating from Overweight to Neutral and lowered its target from $72 to $48 per share. The cut and downgrade point down, though $48 remained above Monday's $46.19 close.
BMO lowered PTC's rating from Outperform to Market Perform but raised its target from $164 to $205 per share. Those changes point in different directions, so the report gives no clear overall signal for PTC shares.
Rosenblatt moved Blaize from Buy to Neutral and cut its target from $2 to $0.40 per share. The downgrade and lower target point to a weaker view of Blaize shares.
Follow Gentex Corp (GNTX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GNTX